Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Forest Laboratories

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Forest Laboratories 2013 CNS and cardiovascular sales performance.

Forest Laboratories

Fresenius Kabi buys Akorn and Merck's biosimilar businesses

Fresenius Kabi buys Akorn and Merck's biosimilar businesses Merck kicked off its biosimilar programme in 2012 via an agreement with India's Dr Reddy's Laboratories at a time when the company was facing patent expiries on some

Sam Agus takes up new role at Hansa Medical

Sam Agus takes up new role at Hansa Medical Agus has previously held various leading positions at several pharmaceutical companies includingAbbott Laboratories and most recently at H.Lundbeck A/S as it’s chief specialist, medical affairs neurology.

Merck confirms sale of biosimilar division

Merck confirms sale of biosimilar division The German group kicked off its biosimilar programme in 2012 via an agreement with India's Dr Reddy's Laboratories, at a time when the company was facing patent expiries on

Lucid expands with launch of new strategic consultancy

Lucid expands with launch of new strategic consultancy Prior to that he worked at Abbott Laboratories, holding senior UK and international marketing roles.

Avelumab costs peg back profit at Merck KGaA

Avelumab costs peg back profit at Merck KGaA Overall sales at the group rose 17% to just over 15bn, thanks to largely to the expansion of its laboratory and life sciences division that was swelled by the recent acquisition

[ Previous 5 results ] 15 16 17 18 19 20 21 22 23 24 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics